LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
24h
Praegune
Min
4.23
Max
4.29
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +130.77% upside |
By Acuity
84%
16%
350 / 374 Pingereas Healthcare
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
24. okt 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Loe
24. okt 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Loe
24. okt 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Loe
24. okt 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Loe
24. okt 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 9.9 USD 130.77%
Kõrge 30 USD
Madal 4 USD
Põhineb 6 Wall Streeti analüütiku instrumendi Adverum Biotechnologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
6 ratings
3
Osta
3
Hoia
0
Müü
Põhineb 6 analüütiku instrumendi Adverum Biotechnologies Inc aktsia reitingul - viimase 3 kuu andmed.
By Acuity
Uudiste sentiment
Väga tugevad languse märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
$